Sjöström S, Hartvig P, Persson M P, Tamsen A
Department of Anesthesiology, University Hospital, Uppsala, Sweden.
Anesthesiology. 1987 Dec;67(6):877-88. doi: 10.1097/00000542-198712000-00002.
Five groups of surgical patients, each comprising six individuals, received epidural doses of morphine or meperidine, and the plasma and CSF kinetics were studied. Three groups received epidural doses of morphine 3 mg in 1 or 10 ml or meperidine 30 mg in 1 ml. Cerebrospinal fluid (CSF) and central venous blood opioid concentrations were measured intermittently for 6 h after injection. Two groups received epidural doses of morphine 3 mg in 1 ml or meperidine 30 mg in 1 ml, and opioid CSF concentrations were determined over a 24-h period. Morphine appeared rapidly in plasma, and maximum plasma concentrations were usually detected 5 min after injection and averaged 33 ng.ml-1 in the 1-ml volume group and 40 ng.ml-1 in the 10-ml volume group. The terminal plasma half-life averaged 91 +/- 34 min and 87 +/- 27 min, respectively (mean +/- SEM). Maximal plasma concentrations of meperidine were usually detected 10 or 15 min post-injection and averaged 196 +/- 29 ng.ml-1. The terminal plasma half-life averaged 124 +/- 26 min. Morphine crossed the dura relatively slowly, and the absorption half-life across the dura averaged 22 min. Maximal CSF concentrations were usually seen 60-90 min post-injection. In contrast, meperidine crossed the dura quickly, with an absorption half-life averaging 7.6 +/- 2.0 min. Maximal CSF concentrations were seen 15 or 30 min post-injection. Morphine and meperidine concentrations remained several times higher in the CSF than in the plasma. The fraction of the opioid dose crossing the dura was calculated to be 3.6% for morphine and 3.7% for meperidine. There were no significant differences in the kinetics of morphine administered in 1 or in 10 ml when CSF was sampled close to the site of lumbar epidural injection. The CSF concentration-time curves of both drugs decreased biexponentially after the initial rise due to diffusion across the dura. The early half-life in CSF averaged 73.3 +/- 11.5 min for morphine and 71.3 +/- 3.1 min for meperidine, and the late half-life averaged 369 +/- 113 min for morphine and 982 +/- 449 min for meperidine. Dose-normalized morphine and meperidine CSF concentrations after epidural administration showed that meperidine concentrations were down to one-fourth the corresponding morphine concentrations from the 2nd to the 15th h after administration, which may partly explain the longer duration of analgesia from morphine.(ABSTRACT TRUNCATED AT 400 WORDS)
五组外科手术患者,每组六人,接受了硬膜外注射吗啡或哌替啶,并对其血浆和脑脊液动力学进行了研究。三组患者接受了硬膜外注射1或10毫升含3毫克吗啡或1毫升含30毫克哌替啶。注射后6小时内间歇性测量脑脊液(CSF)和中心静脉血中的阿片类药物浓度。两组患者接受硬膜外注射1毫升含3毫克吗啡或1毫升含30毫克哌替啶,并在24小时内测定阿片类药物的脑脊液浓度。吗啡在血浆中出现迅速,通常在注射后5分钟检测到最大血浆浓度,1毫升剂量组平均为33纳克/毫升,10毫升剂量组平均为40纳克/毫升。终末血浆半衰期平均分别为91±34分钟和87±27分钟(均值±标准误)。哌替啶的最大血浆浓度通常在注射后10或15分钟检测到,平均为196±29纳克/毫升。终末血浆半衰期平均为124±26分钟。吗啡穿过硬脑膜相对较慢,穿过硬脑膜的吸收半衰期平均为22分钟。最大脑脊液浓度通常在注射后60 - 90分钟出现。相比之下,哌替啶穿过硬脑膜很快,吸收半衰期平均为7.6±2.0分钟。最大脑脊液浓度在注射后15或30分钟出现。吗啡和哌替啶在脑脊液中的浓度比在血浆中高几倍。计算得出,穿过硬脑膜的吗啡剂量分数为3.6%,哌替啶为3.7%。当在靠近腰段硬膜外注射部位采集脑脊液时,1毫升和10毫升剂量的吗啡动力学无显著差异。由于药物通过硬脑膜扩散,两种药物的脑脊液浓度 - 时间曲线在初始上升后均呈双指数下降。吗啡在脑脊液中的早期半衰期平均为73.3±11.5分钟,哌替啶为71.3±3.1分钟,晚期半衰期吗啡平均为369±113分钟,哌替啶为982±449分钟。硬膜外给药后,按剂量标准化的吗啡和哌替啶脑脊液浓度显示,给药后第2至15小时,哌替啶浓度降至相应吗啡浓度的四分之一,这可能部分解释了吗啡镇痛持续时间更长的原因。(摘要截取自400字)